VNDA icon

Vanda Pharmaceuticals
VNDA

Overview Fund Activity

109 hedge funds and large institutions have $538M invested in Vanda Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 43 increasing their positions, 32 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
-1
Holders Change %
-0.91%
% of All Funds
2.94%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
18
Increased
43
Reduced
32
Closed
19
Calls
$8.52M
Puts
$4.72M
Net Calls
+$3.79M
Net Calls Change
-$23.8M

Top Buyers

1
ACA
1
Avoro Capital Advisors
New York
$18.3M
2
EAM
2
EverPoint Asset Management
Connecticut
$11.4M
3
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$11M
4
DM
4
Deerfield Management
New York
$60.7M
5
GTC
5
Ghost Tree Capital
New York
$4.44M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$0
2
Goldman Sachs
2
Goldman Sachs
New York
$36M
3
BBA
3
Baker Bros. Advisors
New York
$5.2M
4
AC
4
Armistice Capital
New York
$14.5M
5
JG
5
Jefferies Group
New York
$1.07M
Name Holding Trade Value Shares
Change 		Shares
Change %
TD Asset Management
126
TD Asset Management
Ontario, Canada
– -$148K -15,900 Closed
Federated Hermes
127
Federated Hermes
Pennsylvania
– -$144K -15,500 Closed
Squarepoint
128
Squarepoint
New York
– -$128K -13,800 Closed
2 3 4 5
6